-+ 0.00%
-+ 0.00%
-+ 0.00%

Q32 BIO PRESENTS RESULTS FROM PART B OF THE SIGNAL-AA CLINICAL TRIAL OF BEMPIKIBART IN ALOPECIA AREATA IN A LATE-BREAKER AT THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY CONGRESS 2026

Reuters·09/30/2026 13:15:01

Please log in to view news